Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019
- PMID: 35732253
- DOI: 10.1016/j.ajic.2022.06.016
Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019
Abstract
Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.
Keywords: Epidemiology; NVHAP; Non-ventilator Hospital-acquired pneumonia; Nosocomial infection.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
